Patents by Inventor Donna K. Slonim

Donna K. Slonim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7611839
    Abstract: Methods, systems and equipment for diagnosing renal cell carcinoma (RCC) and other solid tumors. This invention identifies numerous disease genes that are differentially expressed in the peripheral blood of patients having RCC or other solid tumors relative to disease-free humans. These disease genes can be used as surrogate markers for detecting the presence or absence of RCC or other solid tumors.
    Type: Grant
    Filed: November 21, 2003
    Date of Patent: November 3, 2009
    Assignee: Wyeth
    Inventors: Natalie C. Twine, Michael E. Burczynski, William L. Trepicchio, Andrew J. Dorner, Jennifer A. Stover, Donna K. Slonim
  • Patent number: 7324926
    Abstract: Methods and apparatus for classifying or predicting the classes for samples based on gene expression are described. Also described are methods and apparatus for ascertaining or discovering new, previously unknown classes based on gene expression. Methods, computer systems and apparatus for classifying or predicting whether a sample is treatment sensitive (e.g., chemosensitive) or treatment resistant (e.g., chemoresistant) are also provided. Classification occurs based on analysis of gene expression data from samples that have been subjected to one or more compounds.
    Type: Grant
    Filed: October 1, 2001
    Date of Patent: January 29, 2008
    Assignees: Whitehead Institute for Biomedical Research, Dana-Farber Cancer Institute, Inc.
    Inventors: Pablo Tamayo, Jane E. Staunton, Donna K. Slonim, Hilary A. Coller, Todd R. Golub, Eric S. Lander, Jill P. Mesirov
  • Publication number: 20040110221
    Abstract: Methods, systems and equipment for diagnosing renal cell carcinoma (RCC) and other solid tumors. This invention identifies numerous disease genes that are differentially expressed in the peripheral blood of patients having RCC or other solid tumors relative to disease-free humans. These disease genes can be used as surrogate markers for detecting the presence or absence of RCC or other solid tumors.
    Type: Application
    Filed: November 21, 2003
    Publication date: June 10, 2004
    Applicant: Wyeth
    Inventors: Natalie C. Twine, Michael E. Burczynski, William L. Trepicchio, Andrew J. Dorner, Jennifer A. Stover, Donna K. Slonim
  • Publication number: 20030073083
    Abstract: Methods and apparatus for classifying or predicting the classes for samples based on gene expression are described. Also described are methods and apparatus for ascertaining or discovering new, previously unknown classes based on gene expression. Methods, computer systems and apparatus for classifying or predicting whether a sample is treatment sensitive (e.g., chemosensitive) or treatment resistant (e.g., chemoresistant) are also provided. Classification occurs based on analysis of gene expression data from samples that have been subjected to one or more compounds.
    Type: Application
    Filed: October 1, 2001
    Publication date: April 17, 2003
    Inventors: Pablo Tamayo, Jane E. Staunton, Donna K. Slonim, Hilary A. Coller, Todd R. Golub, Eric S. Lander, Jill P. Mesirov